InvestorsHub Logo
Followers 97
Posts 3653
Boards Moderated 0
Alias Born 11/13/2018

Re: Meowza post# 280622

Tuesday, 06/16/2020 4:14:55 PM

Tuesday, June 16, 2020 4:14:55 PM

Post# of 423973
That is medical/insurance malpractice is a very tough case. The problem is that the expanded label approval occurred in mid-December, too late to update the formularies. So it is my understanding that the problem could correct itself by 2021. I could be wrong, but that is the biggest obstacle I currently see. I have taken a lot of notes though, and have not completely ruled it out.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News